These findings suggest that LARP6 may play a dual role in breast cancer progression—directly promoting cancer cell proliferation through cell cycle regulation as demonstrated in our functional studies, while simultaneously modulating the tumour immune microenvironment. The gene discussed is LARP6; the disease is breast carcinoma.